Physician
Physicians Clinic INC
Physicians Clinic INC was paid $20.46M by Medicaid between Jan 2018 and Dec 2024, across 143 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoPHYSICIANS CLINIC INC
OMAHA, NE 68114
OMAHA, NE 68114
33aNPI1821049156assigned 05/12/2006
33bProvider typeDermatology Physician
28Total paid$20.46M
24GClaims576,649
24DCodes billed143
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Dermatology Physician providers in Nebraska
Rank by total paid#1 of 15
Median peer was paid$49K
This provider vs. median415×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 74,536 | $2.44M | |
| 2019 | 78,213 | $2.65M | |
| 2020 | 64,311 | $2.10M | |
| 2021 | 83,789 | $2.91M | |
| 2022 | 107,339 | $4.02M | |
| 2023 | 104,014 | $3.93M | |
| 2024incomplete | 64,447 | $2.40M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 168,789 | 155,853 | $7.44M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 81,242 | 74,572 | $4.27M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.7% | 14,752 | 14,173 | $1.17M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.3% | 13,120 | 12,909 | $1.09M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 2.8% | 763 | 687 | $582K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.6% | 8,464 | 8,185 | $534K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.5% | 18,766 | 6,819 | $518K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.5% | 6,360 | 6,258 | $508K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.0% | 4,631 | 4,529 | $412K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.7% | 3,866 | 3,726 | $339K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.5% | 28,537 | 27,836 | $310K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.3% | 4,963 | 4,747 | $265K |
131 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 7,264 | $256K |
| 90686 | 1.1% | 21,970 | $222K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.1% | 11,897 | $220K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 23,629 | $198K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,319 | $176K |
| 36415 | Collection of venous blood by venipuncture | <1% | 51,934 | $150K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,289 | $150K |
| 95886 | <1% | 1,613 | $128K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,515 | $120K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,878 | $101K |
| 99460 | <1% | 1,274 | $99K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 1,047 | $91K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,569 | $90K |
| 90670 | <1% | 9,243 | $81K | |
| 93000 | <1% | 4,504 | $69K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,493 | $57K |
| 64644 | <1% | 873 | $49K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 2,151 | $47K |
| 90698 | <1% | 6,292 | $42K | |
| 96127 | <1% | 1,621 | $41K | |
| 93971 | <1% | 1,546 | $32K | |
| 90680 | <1% | 5,201 | $31K | |
| 95911 | <1% | 210 | $28K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 561 | $27K |
| 95909 | <1% | 257 | $24K | |
| 99177 | <1% | 2,525 | $23K | |
| 95806 | <1% | 277 | $22K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 917 | $22K |
| 97802 | <1% | 236 | $22K | |
| 90474 | <1% | 3,196 | $21K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,287 | $20K |
| 83655 | <1% | 1,439 | $19K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,770 | $18K |
| 90651 | <1% | 934 | $18K | |
| 90633 | <1% | 2,619 | $15K | |
| 90734 | <1% | 826 | $15K | |
| 99223 | Prolong inpt eval add15 m | <1% | 149 | $14K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 147 | $13K |
| 95873 | <1% | 1,002 | $12K | |
| 87430 | <1% | 1,065 | $11K | |
| 20610 | <1% | 430 | $11K | |
| 93970 | <1% | 290 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,233 | $8K |
| 94060 | <1% | 279 | $8K | |
| 99462 | <1% | 214 | $8K | |
| 99173 | <1% | 4,009 | $8K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 110 | $8K |
| 90744 | <1% | 1,925 | $8K | |
| 90710 | <1% | 432 | $7K | |
| 85027 | <1% | 1,151 | $7K | |
| 93296 | <1% | 603 | $6K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 129 | $6K |
| 90648 | <1% | 314 | $6K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 269 | $6K |
| 90656 | <1% | 931 | $6K | |
| 99307 | <1% | 426 | $5K | |
| 90723 | <1% | 278 | $5K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 676 | $5K |
| 90715 | <1% | 340 | $5K | |
| 93018 | <1% | 416 | $5K | |
| 90697 | <1% | 1,337 | $5K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 99 | $5K |
| 85018 | <1% | 1,822 | $4K | |
| E0603 | Breast pump, electric (ac and/or dc), any type | <1% | 38 | $4K |
| 87081 | <1% | 590 | $4K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 69 | $4K |
| 90677 | <1% | 946 | $3K | |
| 94729 | <1% | 150 | $3K | |
| 59025 | Fetal non-stress test | <1% | 63 | $3K |
| 76830 | Ultrasound, transvaginal | <1% | 50 | $3K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 60 | $3K |
| 93224 | <1% | 28 | $3K | |
| 93016 | <1% | 168 | $3K | |
| 90696 | <1% | 202 | $2K | |
| 54150 | <1% | 27 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 26 | $2K |
| 94726 | <1% | 85 | $2K | |
| 99384 | <1% | 20 | $2K | |
| 81003 | <1% | 1,224 | $2K | |
| 90619 | <1% | 69 | $2K | |
| 69210 | <1% | 40 | $2K | |
| 90716 | <1% | 136 | $1K | |
| 99490 | Ccm add 20min | <1% | 210 | $1K |
| 95251 | <1% | 37 | $1K | |
| 95819 | <1% | 25 | $1K | |
| 90707 | <1% | 149 | $929.42 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 12 | $861.00 |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 13 | $828.38 |
| 87480 | <1% | 45 | $806.97 | |
| 90620 | <1% | 59 | $800.15 | |
| 87660 | <1% | 45 | $793.80 | |
| 87510 | <1% | 45 | $755.63 | |
| 90621 | <1% | 28 | $740.39 | |
| 99000 | <1% | 638 | $681.08 | |
| 93294 | <1% | 56 | $676.67 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 12 | $492.00 |
| 90672 | <1% | 26 | $455.86 | |
| 84703 | <1% | 59 | $444.18 | |
| 92552 | <1% | 27 | $382.51 | |
| 87210 | <1% | 79 | $367.87 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 246 | $329.66 |
| 93227 | <1% | 14 | $329.20 | |
| 0124A | <1% | 15 | $320.00 | |
| 90685 | <1% | 158 | $311.41 | |
| 3044F | <1% | 837 | $300.46 | |
| 92567 | <1% | 19 | $300.09 | |
| 90647 | <1% | 15 | $297.40 | |
| 99188 | <1% | 26 | $290.05 | |
| 64645 | <1% | 13 | $274.57 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 123 | $265.61 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $248.77 |
| 73030 | <1% | 15 | $246.59 | |
| 94618 | <1% | 12 | $229.11 | |
| 87807 | <1% | 17 | $224.00 | |
| 81001 | <1% | 90 | $208.22 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 16 | $190.43 |
| 90694 | <1% | 16 | $122.00 | |
| 90660 | <1% | 13 | $120.12 | |
| 96160 | <1% | 81 | $98.70 | |
| 99406 | <1% | 31 | $95.10 | |
| 99152 | <1% | 15 | $86.91 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 14 | $62.58 |
| 82465 | <1% | 13 | $58.38 | |
| 85014 | <1% | 12 | $23.60 | |
| 36416 | <1% | 103 | $9.51 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 43 | $6.24 |
| G0008 | Administration of influenza virus vaccine | <1% | 152 | $5.09 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 37 | $3.92 |
| 99024 | 0% | 388 | $0.00 | |
| 96161 | 0% | 30 | $0.00 | |
| 90653 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRAGES, TODD (PRESIDENT)